Blood Test Device Detects 5 Cancers From Single Sample

Imagine walking into your doctor's office for a regular checkup and walking out knowing whether you have cancer, what type it is, and how to treat it—all from one simple blood sample.

Scientists at Mass General Brigham just made that future a huge step closer. Their new device, called SpinEx, can detect five different types of cancer from a tiny blood sample, processing everything automatically on a single spinning disc about the size of a CD.

Here's why this matters. Current cancer detection often requires invasive biopsies, expensive imaging, or multiple separate tests. By the time symptoms appear, cancer may have already progressed. This new technology looks for microscopic particles called extracellular vesicles that cancer cells shed into the bloodstream, catching potential problems much earlier.

The device works like a miniature laboratory. Blood goes in one end, and the spinning motion separates plasma, concentrates these tiny cancer-signaling particles, and labels multiple proteins—all without human handling. Within hours, doctors get results that can distinguish between cancer and healthy samples, and even identify which of five cancer types a patient might have.

In testing, SpinEx accurately separated cancer patients from healthy individuals and correctly classified different tumor types. The system needs just 150 microliters of blood—about three drops—to work its magic.

Why This Inspires

Dr. Hakho Lee, who led the research team, said the most meaningful part wasn't just the technology itself. It was proving that complex cancer detection could finally escape the laboratory and become practical for everyday medical care.

For decades, scientists have known that tiny particles in our blood carry clues about cancer. But analyzing them required tedious manual work, specialized equipment, and multiple fragmented steps. Many promising discoveries never reached patients because they simply weren't practical for hospitals to use.

SpinEx changes that equation. Because it's automated and designed for processing many samples at once, hospitals could realistically offer this screening to large numbers of patients. Early detection dramatically improves cancer survival rates, and this technology could catch cancers before patients even feel sick.

The research, published in Nature Biomedical Engineering, represents years of work at the intersection of engineering and medicine. The team had to miniaturize complex laboratory procedures, ensure accuracy with minimal blood, and make the entire process reliable enough for clinical use.

Looking ahead, this technology could transform cancer care from reactive to proactive. Instead of waiting for symptoms or risk factors, people might receive regular cancer screenings as routinely as they get cholesterol checks. Earlier detection means more treatment options, better outcomes, and more lives saved.

The device still needs larger clinical trials before becoming widely available, but the proof of concept is solid. What once required multiple specialists, expensive equipment, and invasive procedures might soon fit on a disc smaller than your palm.